Ticker Details
Aligos Therapeutics, Inc.
IPO Date:	October 16, 2020
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$39.85M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.43 | 4.39%
Avg Daily Range (30 D):	$0.25 | 3.53%
Avg Daily Range (90 D):	$0.30 | 3.91%

Institutional Daily Volume
Avg Daily Volume:	.22M
Avg Daily Volume (30 D):	.31M
Avg Daily Volume (90 D):	.14M

Trade Size
Avg Trade Size (Sh.):	152
Avg Trade Size (Sh.) (30 D):	74
Avg Trade Size (Sh.) (90 D):	76

Institutional Trades
Total Institutional Trades:	103
Avg Institutional Trade:	$2.37M
Avg Institutional Trade (30 D):	$1.07M
Avg Institutional Trade (90 D):	$1.07M
Avg Institutional Trade Volume:	.01M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$4.3M
Avg Closing Trade (30 D):	$.69M
Avg Closing Trade (90 D):	$.69M
Avg Closing Volume:	13.54K

News

Apr 16, 2026 @ 10:00 AM Aligos Therapeutics Enters into Exclusive License ... Source: Na

Mar 5, 2026 @ 1:00 PM Aligos Therapeutics Reports Recent Business Progre... Source: Aligos Therapeutics, Inc.

Feb 23, 2026 @ 1:00 PM Aligos Therapeutics Presents Positive Data at the ... Source: Not Specified

Jan 30, 2026 @ 1:00 PM Aligos Therapeutics Announces Inducement Grants Un... Source: Na

Dec 12, 2025 @ 1:00 PM Aligos Therapeutics Announces Inducement Grants Un... Source: Jordyn Tarazi

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-8.79	$-2.21	$-2.01
Diluted EPS	$-8.79	$-2.21	$-2.01
Revenue	$4.71M	$2.83M	$.17M
Gross Profit
Net Income / Loss	$-90.32M	$-23.04M	$-19.88M
Operating Income / Loss	$-95.67M	$-26.93M	$-21.81M
Cost of Revenue
Net Cash Flow	$-43.72M	$11.74M	$-23.64M
PE Ratio

Splits
Aug 19, 2024	1:25